Suppr超能文献

去分化软骨肉瘤:我们对25例病例的临床病理经验及困境

Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.

作者信息

Sopta Jelena, Dordević Aleksandar, Tulić Goran, Mijucić Vesna

机构信息

Institute of Pathology, School of Medicine, Belgrade, Serbia.

出版信息

J Cancer Res Clin Oncol. 2008 Feb;134(2):147-52. doi: 10.1007/s00432-007-0262-5. Epub 2007 Jul 25.

Abstract

BACKGROUND

Dedifferentiated chondrosarcoma represents a special form of the chondrosarcoma characterized by the presence of well-differentiated cartilaginous component in juxtaposition with the malignant mesenchymal tumor of high-malignancy grade.

METHODS

The study was performed on 25 tissue samples obtained by biopsy of the primary malignant bone tumors.

RESULTS

Out of the total of 25 patients, 13 were males and 12 were females. Their average age was 59.9 years (39-75). Radiological examination verified the presence of the pathological fractures in 14 patients. The skeletal distribution clearly indicates that the femur is the most frequent site of affection (in 15 patients--60%). Morphological analysis verified the presence of "precursor cartilaginous lesion" or low-grade cartilaginous component in all cases. Classification of the high-grade components was based on the immunohistochemical analyses, which evidenced MFH in 18 cases, osteosarcoma in 4, while fibrosarcoma was evidenced in 2 and rhabdomyosarcoma in 1 case. In 20 patients, out of whom 14 had existing fractures, amputation was indicated. In five patients (fracture-free), resection limb-salvage surgical intervention was performed.

CONCLUSION

The lethal outcome ensues within less than 2 years in all patients.

摘要

背景

去分化软骨肉瘤是软骨肉瘤的一种特殊形式,其特征是存在高分化软骨成分与高恶性级别的恶性间充质肿瘤并存。

方法

本研究对25例原发性恶性骨肿瘤活检获取的组织样本进行。

结果

25例患者中,男性13例,女性12例。平均年龄59.9岁(39 - 75岁)。影像学检查证实14例患者存在病理性骨折。骨骼分布情况清楚表明,股骨是最常受累部位(15例患者,占60%)。形态学分析证实所有病例均存在“软骨前体病变”或低级别软骨成分。高级别成分的分类基于免疫组化分析,结果显示18例为恶性纤维组织细胞瘤,4例为骨肉瘤,2例为纤维肉瘤,1例为横纹肌肉瘤。20例患者(其中14例已有骨折)需行截肢术。5例(无骨折)患者接受了保肢手术切除干预。

结论

所有患者均在不到2年内出现致命结局。

相似文献

1
Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.
J Cancer Res Clin Oncol. 2008 Feb;134(2):147-52. doi: 10.1007/s00432-007-0262-5. Epub 2007 Jul 25.
3
Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature.
Arch Orthop Trauma Surg. 2018 Jul;138(7):929-937. doi: 10.1007/s00402-018-2930-0. Epub 2018 Apr 10.
4
Dedifferentiated chondrosarcoma--a fatal disease.
J Cancer Res Clin Oncol. 2005 Jun;131(6):333-9. doi: 10.1007/s00432-004-0648-6. Epub 2005 Mar 23.
9
Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma.
J Cancer Res Clin Oncol. 2003 Oct;129(10):583-8. doi: 10.1007/s00432-003-0470-6. Epub 2003 Aug 28.
10
Microwave ablation combined with curettage for low-grade chondrosarcomas in the extremities: a single-center study.
BMC Musculoskelet Disord. 2025 Jul 7;26(1):660. doi: 10.1186/s12891-025-08787-6.

引用本文的文献

2
A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Curr Oncol. 2024 Jan 19;31(1):566-578. doi: 10.3390/curroncol31010040.
3
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets.
Curr Oncol Rep. 2023 Oct;25(10):1117-1126. doi: 10.1007/s11912-023-01441-1. Epub 2023 Aug 21.
4
Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.
BMC Musculoskelet Disord. 2021 Feb 15;22(1):189. doi: 10.1186/s12891-021-04053-7.
5
Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. Epub 2019 Feb 8.
6
Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients.
PLoS One. 2017 Mar 16;12(3):e0173665. doi: 10.1371/journal.pone.0173665. eCollection 2017.
7
The clinical management of chondrosarcoma.
Curr Treat Options Oncol. 2009 Apr;10(1-2):94-106. doi: 10.1007/s11864-009-0088-2. Epub 2009 Feb 24.
8
Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.
Diagn Pathol. 2008 Jul 15;3 Suppl 1(Suppl 1):S25. doi: 10.1186/1746-1596-3-S1-S25.

本文引用的文献

1
Dedifferentiated central chondrosarcoma.
Cancer. 2006 Jun 15;106(12):2682-91. doi: 10.1002/cncr.21936.
2
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.
Lancet Oncol. 2005 Aug;6(8):599-607. doi: 10.1016/S1470-2045(05)70282-5.
3
Dedifferentiated chondrosarcoma--a fatal disease.
J Cancer Res Clin Oncol. 2005 Jun;131(6):333-9. doi: 10.1007/s00432-004-0648-6. Epub 2005 Mar 23.
5
Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy.
Clin Radiol. 2004 Mar;59(3):268-72. doi: 10.1016/j.crad.2003.08.009.
6
Dedifferentiated chondrosarcoma of the larynx.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Mar;97(3):369-75. doi: 10.1016/j.tripleo.2003.09.015.
8
Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma.
Pathol Res Pract. 2003;199(6):437-44. doi: 10.1078/0344-0338-00443.
10
Cytogenetic findings in a case of dedifferentiated chondrosarcoma.
Cancer Genet Cytogenet. 2003 Jul 1;144(1):61-4. doi: 10.1016/s0165-4608(02)00866-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验